Advertisement
Advertisement
EOLS
Evolus, Inc. Common Stock
4.50
USDSponsored
+0.08
+1.93%
Feb 06, 15:59 UTC -5
Closed
After-Market
4.49
-0.01
-0.20%
EOLS Earnings Reports
Positive Surprise Ratio
EOLS beat 20 of 32 last estimates.
63%
Next Report
Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
$91.72M
/$0.07
Implied change from Q3 25 (Revenue/ EPS)
+32.99%
/-163.64%
Implied change from Q4 24 (Revenue/ EPS)
+16.18%
/+75.00%
Evolus, Inc. Common Stock earnings per share and revenue
On Nov 05, 2025, EOLS reported earnings of -0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.17 USD, resulting in a 37.50% surprise. Revenue reached 68.97 million, compared to an expected 68.80 million, with a 0.25% difference. The market reacted with a +5.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 0.07 USD, with revenue projected to reach 91.72 million USD, implying an decrease of -163.64% EPS, and increase of 32.99% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
FAQ
What were Evolus, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Evolus, Inc. Common Stock reported EPS of -$0.11, beating estimates by 37.5%, and revenue of $68.97M, 0.25% above expectations.
How did the market react to Evolus, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 5.43%, changed from $6.81 before the earnings release to $7.18 the day after.
When is Evolus, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 02, 2026.
What are the forecasts for Evolus, Inc. Common Stock's next earnings report?
Based on 8
analysts, Evolus, Inc. Common Stock is expected to report EPS of $0.07 and revenue of $91.72M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement